Parnell Pharmaceuticals Holdings Ltd reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was AUD 34.34 million compared to AUD 30 million a year ago. Net loss was AUD 1.42 million compared to AUD 15.06 million a year ago.

Basic loss per share from continuing operations was AUD 0.05 compared to AUD 0.81 a year ago.